Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab

SIMPLE SUMMARY: Cutaneous B-cell lymphomas (CBCL) are a heterogeneous group of mature B-cells neoplasms that present in the skin without evidence of nodal or systemic involvement. Despite being indolent in nature, they tend to recur in a third of patients after treatment. As repetitive treatments ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzer, Christian, Rendon, Adriana, Hassel, Jessica C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564090/
https://www.ncbi.nlm.nih.gov/pubmed/36230709
http://dx.doi.org/10.3390/cancers14194787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564090/
https://www.ncbi.nlm.nih.gov/pubmed/36230709
http://dx.doi.org/10.3390/cancers14194787

Ejemplares similares